143 related articles for article (PubMed ID: 20232367)
1. Effect of encapsulation or grafting on release kinetics of recombinant human bone morphogenetic protein-2 from self-assembled poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
Mercado AE; Jabbari E
Microsc Res Tech; 2010 Sep; 73(9):824-33. PubMed ID: 20232367
[TBL] [Abstract][Full Text] [Related]
2. The release characteristics of a model protein from self-assembled succinimide-terminated poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
Mercado AE; He X; Xu W; Jabbari E
Nanotechnology; 2008 Aug; 19(32):325609. PubMed ID: 21828822
[TBL] [Abstract][Full Text] [Related]
3. Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles.
Mercado AE; Ma J; He X; Jabbari E
J Control Release; 2009 Dec; 140(2):148-56. PubMed ID: 19699244
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
He X; Ma J; Mercado AE; Xu W; Jabbari E
Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
[TBL] [Abstract][Full Text] [Related]
5. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
Duggirala SS; Mehta RC; DeLuca PP
Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
[TBL] [Abstract][Full Text] [Related]
6. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
7. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
[TBL] [Abstract][Full Text] [Related]
8. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2.
Kato M; Namikawa T; Terai H; Hoshino M; Miyamoto S; Takaoka K
Biomaterials; 2006 Jul; 27(21):3927-33. PubMed ID: 16564087
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels.
Hiemstra C; Zhong Z; Van Tomme SR; van Steenbergen MJ; Jacobs JJ; Otter WD; Hennink WE; Feijen J
J Control Release; 2007 Jun; 119(3):320-7. PubMed ID: 17475360
[TBL] [Abstract][Full Text] [Related]
10. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).
Kato M; Toyoda H; Namikawa T; Hoshino M; Terai H; Miyamoto S; Takaoka K
Biomaterials; 2006 Mar; 27(9):2035-41. PubMed ID: 16256191
[TBL] [Abstract][Full Text] [Related]
11. Microporous structure and drug release kinetics of polymeric nanoparticles.
Sant S; Thommes M; Hildgen P
Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
[TBL] [Abstract][Full Text] [Related]
12. Material properties and cytocompatibility of injectable MMP degradable poly(lactide ethylene oxide fumarate) hydrogel as a carrier for marrow stromal cells.
He X; Jabbari E
Biomacromolecules; 2007 Mar; 8(3):780-92. PubMed ID: 17295540
[TBL] [Abstract][Full Text] [Related]
13. In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels.
Fu Y; Du L; Wang Q; Liao W; Jin Y; Dong A; Chen C; Li Z
Pharmazie; 2012 Apr; 67(4):299-303. PubMed ID: 22570935
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
17. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
19. Modeling and experimental investigation of rheological properties of injectable poly(lactide ethylene oxide fumarate)/hydroxyapatite nanocomposites.
Sarvestani AS; Jabbari E
Biomacromolecules; 2006 May; 7(5):1573-80. PubMed ID: 16677041
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
